The data therefore confirm the established oncogenic roles for proteins like Akt, survivin, Bcl-2 and ERK in angiosarcomas and expand the pharmacological utility of specific inhibitors to murine VEGF-dependent angiosarcomas. The gene discussed is AKT1; the disease is angiosarcoma.